MedPath

GAL an early biomarker for acute kidney injury

Completed
Conditions
AKIBiomarkers
Registration Number
NL-OMON21935
Lead Sponsor
-
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
700
Inclusion Criteria

All consequetively admitted patients on a general adult IC

Exclusion Criteria

1. Age under 18

2. Nefrectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observational study
Secondary Outcome Measures
NameTimeMethod
Observational study
© Copyright 2025. All Rights Reserved by MedPath